David A. Siegel Mannkind Corp Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Mannkind Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,647,727 shares of MNKD stock, worth $11.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,647,727
Previous 1,327,627
24.11%
Holding current value
$11.8 Million
Previous $6.01 Million
43.02%
% of portfolio
0.02%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding MNKD
# of Institutions
228Shares Held
133MCall Options Held
1.43MPut Options Held
851K-
Black Rock Inc. New York, NY22.6MShares$162 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$111 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$72.3 Million5.97% of portfolio
-
State Street Corp Boston, MA9.56MShares$68.5 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.76MShares$62.8 Million0.62% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.85B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...